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Restriction endonuclease MboI cleavage of DNA was inhibited by actinomycin D and distamycin A. The 
two inhibitors protected different subsets of the 8 cleavage sites in polyoma DNA. The cleavage reactions 
were analyzed both in the presence of minimal inhibitory concentrations of the compounds and at higher 
concentrations, allowing cleavage at only 1 site/DNA molecule. The experiments showed that cleavage 
sites most efficiently protected by actinomycin D had putative inhibitor binding sites at a distance of 1-2 
base pairs from the MboI recognition sequence. Distamycin A, in contrast, apparently has to bind imme- 
diately adjacent to the MboI recognition sequence to protect from cleavage. 
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1. INTRODUCTION 
Restriction endonucleases recognize and cleave 
double-stranded DNA at specific base sequences 
[ 11. Nosikov et al. reported [2] that the DNA bind- 
ing compounds actinomycin D and distamycin A 
inhibit cleavage of DNA by a number of different 
restriction endonucleases. Actinomycin D interca- 
lates between the bases of dG-dC dinucleotide 
residues in duplex DNA [3], whereas distamycin A 
binds by both electrostatic and non-ionic forces to 
runs of dT residues [4,5]. Digestion of phage 
lambda DNA showed that the two inhibitors speci- 
fically protected subsets of restriction endo- 
nuclease cleavage sites with the same recognition 
sequence, suggesting that base sequences con- 
tiguous to the recognition sites are important for 
the inhibition [5]. In these cases, however, the 
binding site of the inhibitor formed part of the re- 
cognition sequence of the enzyme. 
We investigated the effect of actinomycin D and 
distamycin A on Mb01 cleavage of polyoma DNA. 
The Mb01 recognition sequence, GATC [ 11, cannot 
form part of a binding site of the two inhibitors. 
Since the base sequence of polyoma DNA has 
been determined [6], and the Mb01 cleavage site 
Inhibitor b&ding, adjacent to-cleavage site 
occurs eight times (fig.l) we could correlate the 
base sequence at the cleavage sites to the degree of 
protection by the inhibitors. The best protected 
Fig.1. Physical map of polyoma DNA. The positions 
and coordinates of the Mb01 recognition sites relative to 
the single EcoRI site [6] are indicated. 
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cleavage sites had putative actinomycin D or dis- 
tamycin A binding sites within two base pairs 
from, or immediately adjacent to, the GATC se- 
quences, respectively, whereas poorly protected 
sites had inhibitor binding sequences at a distance 
of 4-7 base pairs. 
2. MATERIALS AND METHODS 
Covalently closed circular polyoma DNA [7] at a 
concentration of 15 pg/ml was digested with MboI 
restriction endonuclease (New England Bio-Labs) 
in a medium consisting of 0.01 M Tris-HCl (pH 
7.6) 0.1 M NaCl, 0.01 M MgC12, 0.001 M /3-mer- 
captoethanol and 0.1 mglml of gelatin. Incuba- 
tions were for 1 h using an amount of enzyme suf- 
ficient for the complete digestion of the DNA in 
the uninhibited reactions. Actinomycin D (Sigma 
Chemical Co.) or distamycin A (Boehringer Mann- 
heim GmbH) was added to the reaction mixtures 
before the enzyme. The reactions were terminated 
Table 1 
Analysis by gel electrophoresis of polyoma DNA 
digested with Mb01 in the presence of inhibitors 
Inhibitor 
(W 
% Yield of Mb01 fragment 
-1 -2 -3 -4 -5 -6 
Actinomycin D
_ 100 100 100 100 100 100 
1x10-6 97 85 96 93 99 81 
3x 10-6 97 63 89 69 86 53 
1x 10-s 93 36 87 55 77 36 
3 x 10 -5 35 0 35 14 41 0 





1 x 10 -5 
3x 10-s 
1x10-4 
100 100 100 100 100 100 
107 105 101 85 86 78 
110 107 94 99 95 76 
43 104 83 86 76 0 
24 62 25 23 36 0 
9 26 0 0 12 0 
Covalently closed circular polyoma DNA cleaved with 
MboI was analyzed by gel electrophoresis in 1.5% 
agarose gels. Photographs of ethidium bromide stained 
gels were analyzed by densitometer tracing to quantitate 
DNA in the fragments 
by the addition of phenol. Labeling of 5’-ends 
from [$2P]ATP (The Radiochemical Centre, 
Amersham) using T4 polynucleotide kinase (a gift 
from M.-L. Hammarskjold) was done as described 
by Berkner and Folk [8]. 
Gel electrophoresis was performed as described 
earlier [9]. 
3. RESULTS AND DISCUSSION 
The effect of actinomycin D and distamycin A 
on Mb01 cleavage was tested by two methods. In 
the first type of experiment he cleavage reactions 
were performed in the presence of 10 -6- 10 -4 M 
concentrations of the two compounds. The cleav- 
age products were then analyzed by gel electro- 
phoresis (table 1). The patterns of partial cleavage 
products accumulating at increasing inhibitor con- 
centrations were reproducible. However, the 
lowest inhibitory concentration of the compounds 
showed variations between experiments. The inter- 
pretation of these experiments is complicated by 
difficulties in the identification of partial cleavage 
products. 
In the second type of experiment polyoma DNA 
was digested with Mb01 in the presence of ac- 
tinomycin D or distamycin A at concentrations 
which allowed cleavage at, in average, only one 
site per DNA molecule. As a control, DNA was 
partially digested in the absence of inhibitors with 
a small amount of enzyme. The ends of linear 
DNA molecules of full length were labeled with 
s2P. After complete Mb01 digestion, the resulting 
fragments were separated by gel electrophoresis 
and the amount of radioactivity of each fragment 
was determined. In the uninhibited reaction 
(fig.2A) all fragments were labeled to a similar ex- 
tent, suggesting that MboI cleaved all sites of poly- 
oma DNA with the same efficiency. In contrast, 
both actinomycin D (fig.2B) and distamycin A 
(fig.2C) preferentially protected certain cleavage 
sites which was reflected by the unequal labeling 
of the Mb01 generated fragments. The conclusions 
that can be drawn from this experiment alone are 
limited, since the radioactivity of each fragment 
represents the sum of label at the two ends. 
Partial inhibition of MboI cleavage by ac- 
tinomycin D primarily resulted in decreased molar 
yields of fragments MboI-2, -4, and-6. In contrast, 
the generation of MboI-1, -3 and -5 was much 
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Fig.2. Distribution of cleaved recognition sites after par- 
tial digestion of polyoma DNA with MboI. A permuted 
set of linear polyoma DNA molecules was generated by 
partial Mb01 cleavage, either with a small amount of en- 
zyme (A), or in the presence of inhibitors. Actinomycin 
D (B) and distamycin A (C) were used at a con- 
centration of 2 x IO-5 M. In the reaction only trace 
amounts of cleavage products shorter than full length 
linear DNA were formed. The ends of the linear DNA 
molecules were 32P-labeled before cleavage to comple- 
tion with MboI. The resulting fragments were separated 
on polyacrylamide gels and the radioactivity of each 
fragment was determined. In the figure the fragments 
are ordered on a linearized map of polyoma. 
more resistant to inhibition (table 1). Inspection of 
the original photographs of the gels also showed 
that the formation of MboI-7 was quite resistant to 
inhibition. 
Linear DNA molecules formed by MboI cleav- 
age in the presence of actinomycin D predomi- 
nantly ended with MboI-3, -4, -5 and -7. Relatively 
few molecules appeared to be cleaved at the sites 
determining MboI- 1, -2 and -6 (fig.2B). 
Together, the two experiments show that the 
cleavage sites at 34.5 and 58.1 map units, limiting 
MboI-2 from Mb014 and -6, were well protected 
by actinomycin D. Conversely, the sites at 5.6, 
22.7, 93.0,95.4 and 95.5 map units, limiting MboI-3, 
-7 and -8, respectively, were poorly protected. 
Conflicting results were obtained for the formation 
of MboI-1 and -4. The apparently high yield of 
MboI-1 shown in table 1 could result from the ac- 
cumulation of partially cleaved MboI-3 plus -5. It 
is therefore probable that the site at 65.4 units was 
better protected than the site at 93.0 map units, as 
suggested from the data of lig.2B. The relatively 
high radioactivity of Mb014 seen in tig.2B proba- 
bly resulted from effective labeling of the fragment 
at 22.7 map units. 
Distamycin A inhibition primarily decreased the 
yield of the two neighbouring fragments MboI-1 
and -6. At a slightly increased concentration 
(3 x 10-S M) of the compound also the genera- 
tion of the two contiguous fragments MboI-3 and 
-4 was reduced. In contrast, the formation of the 
other fragments was more resistant to inhibition. 
Again, the amount of MboI-1 probably was over- 
estimated (table 1). 
End labeling of DNA molecules showed (tig.2C) 
that circular DNA molecules were most frequently 
cleaved at sites determining MboI-2 and -5, at least 
frequently at sites determining MboI- 1. 
From the two sets of data we conclude that 
Mb01 cleavage at 65.4 map units, between MboI-1 
and -6, was most sensitive to distamycin A, and 
cleavage of the site at 22.7 map units slightly less 
sensitive. At the other end of the scale, the sites at 
34.5, 58.1, 95.5 and 5.6 map units, limiting MboI-2 
and -5, respectively, were least efficiently pro- 
tected. The two remaining cleavage sites at 93.0 
and 95.4 map units were probably protected at in- 
termediate levels. 
The base sequences at the Mb01 cleavage sites 
(table 2) show that the three sites best protected by 
actinomycin D all have a base paired dG-dC di- 
nucleotide residue within two base pairs from the 
GATC recognition sequence. The remaining five 
MboI sites all have other GC rich sequences within 
a distance of a few base pairs, and the site at 95.5 
map units has a dG-dC residue separated by six 
nucleotides from the recognition sequence. 
The two Mb01 sites protected by distamycin A 
have two or three contiguous dT residues next to 
the point of cleavage. Of the relatively unprotected 
sites, one at 95.4 map units has a potential binding 
site separated by 1 base pair from the GATC se- 
quence, whereas another site at 34.5 map units has 
362 
Volume 145, number 2 FEBS LETTERS August 1982 
Table 2 
Base sequences at recognition sites and inhibition of MboI cleavage by actinomycin D 
and distamycin A 
Map position Base sequence Protection by 
Actinomycin D Distamycin A 
5.6 CAACCTTGATGATC CCCTGTTAAT 
GTTGGAACTA CTAG GGGACAATTA 
22.7 AGATGTATTTGATCCTGATATTCA _ + 
TCTACATAA CTAG GACTATAAGT 
34.5 TTTTTTGCTG GATC TGGATGCCAG ++ _ 
AAAAAACGAC CTAG ACCTACGGTC 
58.1 AGAAGGGCTG GATC CCGCCATGGT ++ 
TCTTCCCGAC CTAG GGCGGTACCA 
65.4 TCACTTACTTGATCAGCTTCAGAA ++ ++ 
AGTGAATGAA CTAG TCGAAGTCTT 
93.0 GCCAATGGAG GATC TGTATCCGAT _ 
CGGTTACCTC CTAG ACATAGGGCTA 
95.4 GGCTCATTTC GATC CGATCCTAGA - - 
CCG 4GTAAAG CTAG GCTAGGATCT 
95.5 ATTTCGATCC GATC CTAGATGCGA _ _ 
TAAAGCTAGG CTAG GATCTACGCT 
The base sequences at the eight Mb01 sites [6] are shown with the recognition site of the enzyme 
underlined. The symbols + + , + and - denote the efficiency of protection against MboI cleavage 
by actinomycin D and distamycin A 
a dT6 tract at four base pairs from the recognition 
sequence. Hence it appears that distamycin A mol- 
ecules must bind immediately adjacent o the point 
of cleavage to protect from the Mb01 enzyme. 
The mechanism of actinomycin D and dista- 
mycin A inhibition of MboI cleavage is unknown. 
It is conceivable that the binding of the com- 
pounds at the restriction endonuclease recognition 
sites prevents binding of the enzyme or the cleav- 
age reaction by steric hindrance. Another possible 
mechanism of the inhibition is the structural 
change of the DNA, such as a local unwinding or 
increased melting temperature, which is induced 
by the binding of the two agents [3,4]. Actinomycin 
D and distamycin A present at high concentrations 
inhibited MboI cleavage of polyoma DNA com- 
pletely. Under conditions of partial cleavage, 
however, no cleavage site was completely pro- 
tected. Instead, the relative efficiency of protection 
of the individual sites was similar at high and low 
degrees of inhibition. 
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